BNTX — BIONTECH SE
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BNTX?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 5 tracked investors who changed their BNTX position last quarter, 4 bought and 1 sold (80% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 52/100 in a Squeeze regime).
- +4 tracked investors added or increased positions last quarter (Paul Tudor Jones, Izzy Englander, Ken Griffin, …)
- +5 tracked investors reported holding BNTX at their latest filing
- −1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 8/4/2026.
About BIONTECH SE (BNTX)
BIONTECH SE (BNTX) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $137M. Across recent filings, tracked investors recorded 8 new positions, 0 increased, 0 reduced, and 1 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BNTX
How many top investors track BNTX
A small number of top investors own this.
BNTX Ownership Composition
How BIONTECH SE is held across tracked investor types, based on reported 13F positions.
- Other92.8%
- Growth Funds7.2%
Tracked investors reporting BNTX
- Ken GriffinMar 31, 2026Citadel AdvisorsShares1.5MValue$136.9M% Portfolio0.02%
- Izzy EnglanderMar 31, 2026Millennium ManagementShares55.4KValue$4.9M% Portfolio0.00%
- Cathie WoodMar 31, 2026ARK Investment ManagementShares127.9KValue$11.4M% Portfolio0.09%
- Paul Tudor JonesMar 31, 2026Tudor Investment CorpShares42.5KValue$3.8M% Portfolio0.01%
- Ray DalioDec 31, 2025Bridgewater AssociatesShares4.9KValue$469.1K% Portfolio0.01%
Recent activity
- $281.5KFeb 17, 2026
- $3.8MMay 15, 2026
- $33.5MFeb 17, 2026
- $4.9MMay 15, 2026
- New$136.9MMay 15, 2026
- Sold$0(-100.00%)May 15, 2026
- New$11.4MMay 12, 2026
- New$469.1KFeb 13, 2026
- New$81.3MNov 14, 2025
Frequently asked questions
- How many institutional investors hold BNTX?
- 5 tracked institutional investors disclosed a position in BNTX (BIONTECH SE) in their most recent 13F filing.
- Who is the largest institutional holder of BNTX?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BNTX, valued at $137M.
- Did institutional ownership of BNTX increase or decrease?
- Across recent 13F filings, tracked investors recorded 8 new positions, 0 increased, 0 reduced, and 1 fully exited BNTX.
- Where does this BNTX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.